Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study

Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study

Abstract Background The effects and their magnitudes of sex on disease activity indices for rheumatoid arthritis are not clear. We aimed to comprehensively evaluate the influence of sex on disease activity indices in the real-world setting using a large observational database. Methods We analyzed 14...

Full description

Bibliographic Details
Main Authors:	Takahiro Nishino, Atsushi Hashimoto, Shigeto Tohma, Toshihiro Matsui
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Series:	BMC Rheumatology
Subjects:	Rheumatoid arthritis Disease activity Sex difference DAS28 SDAI CDAI
Online Access:	https://doi.org/10.1186/s41927-023-00328-9

Similar Items

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
by: Kirsten Janke, et al.
Published: (2022-12-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

The role of timely rheumatoid arthritis treatment effectiveness control
by: Larisa M. Musaeva, et al.
Published: (2023-11-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience
by: H. Singh, et al.
Published: (2022-09-01)

The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Mahmood Almurshedi, et al.
Published: (2023-08-01)

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
by: Perebetyuk L.
Published: (2015-09-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Characteristics of Anemia in Rheumatoid Arthritis
by: Anca BOBIRCA, et al.
Published: (2022-09-01)

The Role of Interleukin-22 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Almurshedi, et al.
Published: (2023-06-01)

Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III
by: E. V. Akatova, et al.
Published: (2024-12-01)

The effect of polypharmacy on rheumatoid and psoriatic arthritis treatment: retrospective study
by: Mete Kara, et al.
Published: (2023-11-01)

Correlation between neutrophil-to-lymphocyte ratio and disease activity score using SDAI in established rheumatoid arthritis patients
by: Tabe Rasool, et al.
Published: (2024-06-01)

SERUM FETUIN-A LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Papichev, et al.
Published: (2019-09-01)

The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

Effects of Melatonin on Sleep Quality and Disease Activity in Patients With Rheumatoid Arthritis
by: Tayebeh Palimi, et al.
Published: (2022-06-01)

Hypertension prevalence in rheumatoid arthritis
by: E. V. Arshin
Published: (2005-10-01)

MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
by: Zhang Q, et al.
Published: (2023-05-01)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
by: Jeffrey R. Curtis, et al.
Published: (2023-06-01)

Study of serum calprotectin level in rheumatoid arthritis: unexpected low level and possible explanations
by: Sarah Sayed El-Tawab, et al.
Published: (2024-01-01)

Diagnosis delay in Egyptian rheumatoid-arthritis-patients: underlying factors and outcomes — retrospective observational study
by: Sarah A. Sakr, et al.
Published: (2023-06-01)

Frequency of Thyroid Disorders in Rheumatoid Arthritis Patients and its Association with Disease Activity: A Hospital Based Study
by: Safina Hameed Qureshi, et al.
Published: (2023-06-01)

LEVELS OF ANGIOGENESIS-REGULATORY CHEMOKINES IN THE SYNOVIAL FLUID OF PATIENTS WITH RHEUMATOID ARTHRITIS
by: D. A. Zhebrun, et al.
Published: (2015-03-01)

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
by: I. V. Shirinsky, et al.
Published: (2019-01-01)

IMPACT OF PREGNANCY ON THE ACTIVITY OF RHEUMATOID ARTHRITIS AND ITS THERAPY ACCORDING TO PROSPECTIVE FOLLOW-UP DATA
by: E. V. Matyanova, et al.
Published: (2015-09-01)

Frequency of Positive Anti-CCP Antibodies in Patients of Rheumatoid Arthritis with Negative Rheumatoid Factor: A Cross-sectional Retrospective Data-based Study
by: Nauman Ismat Butt, et al.
Published: (2024-08-01)

Depressão, ansiedade e atividade de doença na artrite reumatóide Depression, anxiety and disease activity in rheumatoid arthritis
by: Antonio Filpi Coimbra da Costa, et al.
Published: (2008-02-01)

Expression of CD69 molecule in Rheumatoid Arthritis Iraqi patients
by: Hayfaa S. AL-Hadithi
Published: (2015-10-01)

Role of Cathepsin G in Rheumatoid Arthritis Diagnosis and Disease Activity Evaluation
by: Mays Saleh Khamees, et al.
Published: (2024-06-01)

The Role of Sex, Perceived Pain, and Illness Perceptions in Disease Activity in Rheumatoid Arthritis
by: Mohammad Raza Seirafi, et al.
Published: (2021-09-01)

Comparison of the clinical effectiveness of US grading scoring system vs MRI in the diagnosis of early rheumatoid arthritis (RA)
by: Huajun Xu, et al.
Published: (2017-10-01)

The Role of IL-37 as an Anti-Inflammatory Biomarker in some Iraqi Rheumatoid Arthritis Patients and Its Correlation with DAS28
by: Sattar Brissm Hassan, et al.
Published: (2022-11-01)

Circulating Interleukin-23 Levels in Rheumatoid Arthritis and its Relationship to Disease Activity: a Systematic Review with Meta-Analysis
by: Ahmed Azzam, et al.
Published: (2023-04-01)

Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico
by: Guillermo Santoscoy‐Ascencio, et al.
Published: (2020-01-01)